Novanta CEO-linked trust sells 7,500 shares at $140

Novanta Inc. disclosed that a trust associated with Chief Executive Officer and director Matthijs Glastra sold common stock under a pre-established trading plan.

Rhea-AI Filing Summary

Novanta Inc. disclosed that a trust associated with Chief Executive Officer and director Matthijs Glastra sold common stock under a pre-established trading plan. On January 21, 2026, the entity sold 7,500 shares of Novanta common stock at $140 per share in an open-market transaction. After this sale, Glastra remained beneficial owner of 71,367 shares held directly, and 54,382 shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. The filing notes that these sales were made under a Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee.

Insider Trade Summary

Net Seller: 7,500 shares

Net Sell 2 txns

Insider Glastra Matthijs

Role Chief Executive Officer

Sold 7,500 shs ($1.05M)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,500	$140.00	$1.05M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 71,367 shares (Direct); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)

Footnotes (1)

1. F1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NOVANTA INC (NOVT) report for Matthijs Glastra?

The company reported that a trust associated with Chief Executive Officer and director Matthijs Glastra sold 7,500 shares of Novanta common stock on January 21, 2026 at $140 per share.

How many NOVT shares does Matthijs Glastra beneficially own after the reported sale?

After the transaction, Matthijs Glastra beneficially owned 71,367 shares of Novanta common stock directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust.

Was the NOVT insider sale by Matthijs Glastra pre-planned under Rule 10b5-1?

Yes. The filing states the sales were made under a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee.

Who executed the sale of Novanta (NOVT) shares reported for Matthijs Glastra?

The sale was effected through a trust, specifically the Matthijs Glastra 2021 Irrevocable Trust, which is associated with the reporting person. The footnote explains that the plan was adopted through a trust for which the reporting person’s spouse is a trustee.

What role does Matthijs Glastra hold at Novanta Inc. (NOVT)?

According to the filing, Matthijs Glastra is a director and Chief Executive Officer of Novanta Inc.

How is the indirect ownership of NOVT shares by Matthijs Glastra structured?

The filing reports 54,382 shares of Novanta common stock held indirectly, with the nature of ownership described as the "Matthijs Glastra 2021 Irrevocable Trust".

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 04:14 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glastra Matthijs

(Last) (First) (Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD MA 01730

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/21/2026		S(1)		7,500	D	$140	71,367	D
Common Stock								54,382	I	Matthijs Glastra 2021 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.